跳至主要内容
临床试验/ACTRN12619001206112
ACTRN12619001206112招募中未知

Ovarian rejuvenation using intra-ovarian injection of autologous platelet-rich plasma (A-PRP) for peri-menopausal and menopausal women.

Fertility North0 个研究点目标入组 400 人开始时间: 2019年8月29日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
Female

入选标准

  • i.Low AMH (<1.5 pmol/L).
  • ii.High basal FSH (>14 mIU/mL).
  • iii.Classified with premature ovarian failure (POF) (Menopausal reproductive hormones <40 years of age).
  • iv.Classified as having poor ovarian response (POR) (As per Bologna Criteria).
  • v.A history of poor IVF outcomes, including failed oocyte retrievals, no mature oocytes available for insemination, failed fertilisation of oocytes, no embryos available for transfer.

排除标准

  • i.Patients with normal hormonal profiles, previous acceptable / good responses to ovarian stimulation and good numbers of embryos available for embryo transfer or cryopreservation (greater than 3).
  • ii.Patients with POF due to a genetic condition e.g. Turners syndrome.
  • iii.Patients with Idiopathic thrombocytopenia (autoimmune platelet deficiency).
  • iv.Patients who are unable to undergo an IVF treatment cycle for any reason.

研究者

相似试验